The APP Brand of Specialty Injectable Products From Fresenius Kabi USA Corporate Profile
 
Select a profile:

The APP Brand of Specialty Injectable Products From Fresenius Kabi USA

Fresenius Kabi is a leading global health care company that focuses on medicines and medical devices for critically and chronically ill patients inside and outside the hospital. Its APP brand of specialty injectable products is well known to hospitals and other health care providers in the United States. Fresenius Kabi provides a full line of critical care, anesthesia/analgesia, oncology and anti-infective products under the APP brand.

At A Glance

Address

Fresenius Kabi USA
Three Corporate Drive
Lake Zurich, IL 60047
Phone: (847) 550-2300
Toll-Free: (888) 391-6300
www.fresenius-kabi.us

Customer Service Ordering

Toll-Free: (888) 386-1300
FAX: (800) 743-7082

Medical Affairs

Toll-Free: (800) 551-7176
FAX: (847) 413-8571

Products

A leading supplier of multisource and branded injectable pharmaceutical products, primarily focused on the anesthesia/analgesia, anti-infective, critical care and oncology markets.


APP products are produced at multiple FDA-registered facilities located throughout the United States, Europe and Asia. To help further ensure that the company can reliably meet the needs of its customers, the global manufacturing capabilities of Fresenius Kabi have been utilized in times of great customer need.

What this ultimately means to health care providers and the patients they serve is that Fresenius Kabi USA has the commitment and resources to provide specialty injectable products that meet the highest quality standards.

Well Prepared To Serve Customer and Patient Needs

Today, providing reliable access to quality specialty injectable products is more important than ever before. As part of a global company, Fresenius Kabi USA is positioned to provide high-quality products to its customers based on the following capabilities:

Together, these capabilities define what customers and patients expect and rely on from a leader focused on supporting the care of critically and chronically ill patients inside and outside the hospital.

A Growing Portfolio of Quality Products

Table. APP Injectable Drug Products
Therapeutic Area Number of Product Families Number of Products
Analgesia and anesthesia 16 124
Anti- infectives 28 79
Critical ?care 54 139
Oncology 27 63

In 2012, Fresenius Kabi USA was the second largest supplier of multisource products based on the number of units sold in the United States and Canada.1 The company ranks first in terms of the number of injectable drugs offered across four key therapeutic areas (Table).

There is a commitment to continually expand its already broad portfolio. Recently, Fresenius Kabi added Meropenem for Injection, USP (IV) and Imipenem and Cilastatin Injection, USP (IV) to its anti-infective portfolio; Acetylcysteine Injection, Tranexamic Acid Injection, Benztropine Mesylate Injection and Levetiracetam Injection to its critical care product line; and Oxaliplatin Injection, USP to its oncology portfolio.

Commitment in Action

Fresenius Kabi USA has the resources to maintain its commitment to providing quality essential medicines. The company’s processes, production capabilities and people demonstrate its commitment in action on a daily basis.

Reference

  1. IMS Health, September 2012.

This corporate profile was reviewed and approved by The APP Brand of Specialty Injectable Products From Fresenius Kabi USA.


Close